Последнее обновление :
17/12/2025

Поиск Поиск

Монография Cyclophosphamide ИнъекцияЦитостатическое средство Cyclophosphamide (Великобритания, Соединённые Штаты Америки, Саудовская Аравия, новая Зеландия)
ATC : L01AA01
Монография Cyclophosphamide Раствор для перорального приёмаЦитостатическое средство ATC : L01AA01
Монография Cyclophosphamide КапсулаЦитостатическое средство ATC : L01AA01
Библиография 40 Pharm Sci Communications Stability and compatibility studies of four cytostatic agents (fluorouracil, dacarbazine, cyclophosphamide and ifosfamide) with PVC infusion bags.
Библиография 50 Am J Health-Syst Pharm Stability of ondansetron hydrochloride and cyclophosphamide in injectable solutions.
Библиография 170 Am J Hosp Pharm Effect of briefly heating cyclophosphamide solutions.
Библиография 172 J Parenter Sci Technol Chemical stability of two sterile, parenteral formulations of cyclophosphamide (Endoxan) after reconstitution and dilution in commonly used infusion fluids.
Библиография 1728 Pharmazie Stability of cyclophosphamide containing infusions.
Библиография 1833 Ann Pharmacotherapy Stability of cyclophosphamide and mesna admixtures in polyethylene infusion bags.
Библиография 2000 J Pharm Biomed Anal Quality control and stability study using HPTLC: applications to cyclophosphamide in various pharmaceutical products.
Библиография 2016 Am J Health-Syst Pharm Compatibility of palonosetron with cyclophosphamide and with ifosfamide during Y-site administration.
Библиография 3096 Ann Pharmacotherapy Stability of Cyclophosphamide in Extemporaneous Oral Suspensions.
Библиография 4865 Dr REDDY laboratoire Cyclophosphamide REDDY PHARMA 2000 mg/4 ML, solution à diluer pour solution injectable/perfusion. - Résumé des caractéristiques du produit.
Библиография 4989 Dr REDDY Extended dilution stability study report of cyclophosphamide concentrate for solution for infusion at room temperature and refrigerated condition ( 2-8°C) - Personal communication - July 2025

  Mentions Légales